WHAT: The Advanced Product Incubator (API) establishes cell-free platforms to develop regenerative therapies. Built according to Current Good Manufacturing Practices (CGMP) set forth by the Food and Drug Administration (FDA), the API adheres to rigorous standards of facility design, monitoring and process control. This multidisciplinary, first-of-its-kind facility bridges teams of researchers and physicians with scientific and industry experts to accelerate product development. The API design fosters the translation of laboratory discoveries into clinical grade curative products developed with the lowest possible risk to patients. API’s unique approach is to develop low-cost, off-the-shelf, cell-free regenerative therapies that address chronic or incurable diseases. Reporters will have a chance to tour portions of the facility, take photos and video, and interview experts. A ribbon cutting ceremony will take place at 4:30 p.m.
WHERE: Minnesota Biobusiness Center, 221 1st Ave. SW, 3rd floor, Rochester, Minnesota.
WHEN: Thursday, June 11, 2015, 4:30 to 5:30 p.m.
WHO: Interviews available with Atta Behfar, M.D., Ph.D., director, Advanced Product Incubator; Andre Terzic, M.D., Ph.D., director, Mayo Clinic Center for Regenerative Medicine; and Gary Smith, president, Rochester Area Economic Development, Inc.
RSVP: Jennifer Schutz, Schutz.firstname.lastname@example.org, 507-284-0025
MEDIA CONTACT: Bob Nellis, Mayo Clinic Public Affairs, 507-284-5005, email@example.com